Adma Biologics Inc (NASDAQ: ADMA) Stock In Prove Me State

Adma Biologics Inc (ADMA) concluded trading on Wednesday at a closing price of $23.61, with 3.78 million shares of worth about $89.27 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 21.89% during that period and on May 07, 2025 the price saw a […]

Adma Biologics Inc (ADMA): Street Finally Waking Up

Currently, there are 236.62M common shares owned by the public and among those 230.23M shares have been available to trade. The company’s stock has a 5-day price change of 24.80% and 51.39% over the past three months. ADMA shares are trading 42.92% year to date (YTD), with the 12-month market performance up to 279.41% higher. […]

Uncovering Institutional Buying In Adma Biologics Inc (NASDAQ: ADMA)

BlackRock Fund Advisors recently announced the acquisition of new stake in Adma Biologics Inc (NASDAQ:ADMA). The institutional investor has increased its shareholding in the Healthcare company by 1.87% to 15.09 million shares with purchase of 0.28 million shares. This fresh investment now brings its stake to 6.68% valued currently at $55.84 million. In addition, The […]

Adma Biologics Inc (NASDAQ: ADMA): Reassessing Prospects

Adma Biologics Inc (ADMA) concluded trading on 12/28/23 at a closing price of $4.52, with 4.18 million shares of worth about $18.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.52% during that period and on Thursday the price saw a gain of […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.